Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hans-Jochem Kolb

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Concepts & Ideas

Living Beings

Dogs

Anatomy

Phenomena

Recurrence

Chemicals & Drugs

Busulfan

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
50
Holler, Ernst
30
Ledderose, Georg
26
Wilmanns, W
25
Schleuning, Michael
23
Pihusch, Rudolf
22
Hiller, Erhard
18
Salat, Christoph
17
Thierfelder, S
15
Hehlmann, Rüdiger
14
Pihusch, Markus
14
Mittermüller, J
12
Hochhaus, Andreas
12
Heimpel, Hermann
11
Schumm, M
11
Hossfeld, Dieter

Sign-in to see all Coauthors

Publications

TOP 3
Bacher Ulrike; Klyuchnikov Evgeny; Zabelina Tatjana; Ottinger Hellmut; Beelen Dietrich W; Schrezenmeier Hubert; Ehninger Gerhard; Müller Carlheinz; Berger Jürgen; Suttorp Meinolf; Kolb Hans-Jochem; Kröger Nicolaus; Zander Axel R
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Kolb Hans-Jochem; Simoes Belinda; Schmid Christoph
Stem cell transplants for patients with relapsed/refractory leukaemia.
Schinwald N; Rank A; Tischer J; Kolb H J
[Steroid-refractory graft-versus-host disease : Extracorporeal irradiation of leucocytes induces immunotolerance.]

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hans-Jochem Kolb (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bacher Ulrike; Klyuchnikov Evgeny; Zabelina Tatjana; Ottinger Hellmut; Beelen Dietrich W; Schrezenmeier Hubert; Ehninger Gerhard; Müller Carlheinz; Berger Jürgen; Suttorp Meinolf; Kolb Hans-Jochem; Kröger Nicolaus; Zander Axel R
The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia--a report from the German Registry covering the period from 1998 to 2004.
Annals of hematology 2009;88(12):1237-47.
2009: Kolb Hans-Jochem; Simoes Belinda; Schmid Christoph
Stem cell transplants for patients with relapsed/refractory leukaemia.
Current opinion in hematology 2009;16(6):444-52.
2009: Schinwald N; Rank A; Tischer J; Kolb H J
[Steroid-refractory graft-versus-host disease : Extracorporeal irradiation of leucocytes induces immunotolerance.]
Der Internist 2009;50(11):1270-5.
2009: Finke Jürgen; Bethge Wolfgang A; Schmoor Claudia; Ottinger Hellmut D; Stelljes Matthias; Zander Axel R; Volin Liisa; Ruutu Tapani; Heim Dominik A; Schwerdtfeger Rainer; Kolbe Karin; Mayer Jiri; Maertens Johan A; Linkesch Werner; Holler Ernst; Koza Vladimir; Bornhäuser Martin; Einsele Hermann; Kolb Hans-Jochem; Bertz Hartmut; Egger Matthias; Grishina Olga; Socié Gérard;
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
The lancet oncology 2009;10(9):855-64.
2009: Kyriakou Charalampia; Canals Carmen; Finke Jürgen; Kobbe Guido; Harousseau Jean-Luc; Kolb Hans-Jochem; Novitzky Nicolas; Goldstone Anthony H; Sureda Anna; Schmitz Norbert
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3951-8.
2009: Zorn Julia; Herber Martin; Schwamberger Sabine; Panzer Werner; Adler Heiko; Kolb Hans-Jochem
Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
Experimental hematology 2009;37(8):998-1006.
2009: Valent Peter; Hofmann Wolf-Karsten; Büsche Guntram; Sotlar Karl; Horny Hans-Peter; Haase Detlef; Haferlach Torsten; Kern Wolfgang; Bettelheim Peter; Baumgartner Christian; Sperr Wolfgang R; Nösslinger Thomas; Wimazal Friedrich; Giagounidis Aristoteles A; Lübbert Michael; Krieger Otto; Kolb Hans-Jochem; Stauder Reinhard; Pfeilstöcker Michael; Gattermann Norbert; Fonatsch Christa; Aul Carlo; Germing Ulrich
Meeting report: Vienna 2008 Workshop of the German-Austrian Working Group for Studying Prognostic Factors in Myelodysplastic Syndromes.
Annals of hematology 2009;88(7):607-11.
2009: Rieger C T; Rieger H; Kolb H J; Peterson L; Huppmann S; Fiegl M; Ostermann H
Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(3):220-6.
2009: Scholl Nina; Loibl Julia; Kremser Andreas; Liepert Anja; Grabrucker Christine; Salih Helmut Rainer; Kolb Hans-Jochem; Schmetzer Helga Maria
The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders.
Leukemia & lymphoma 2009;50(3):427-36.
2009: Buhmann R; Simoes B; Stanglmaier M; Yang T; Faltin M; Bund D; Lindhofer H; Kolb H-J
Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion.
Bone marrow transplantation 2009;43(5):383-97.
2008: Kolb Hans-Jochem
Graft-versus-leukemia effects of transplantation and donor lymphocytes.
Blood 2008;112(12):4371-83.
2008: Ghoreschi Kamran; Thomas Peter; Penovici Marius; Ullmann Johanna; Sander Christian A; Ledderose Georg; Plewig Gerd; Kolb Hans-Jochem; Röcken Martin
PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease.
European journal of dermatology : EJD 2008;18(6):667-70.
2008: Schetelig Johannes; Bornhäuser Martin; Schmid Christoph; Hertenstein Bernd; Schwerdtfeger Rainer; Martin Hans; Stelljes Matthias; Hegenbart Ute; Schäfer-Eckart Kerstin; Füssel Monika; Wiedemann Barbel; Thiede Christian; Kienast Joachim; Baurmann Herrad; Ganser Arnold; Kolb Hans Jochem; Ehninger Gerhard
Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5183-91.
2008: Rieger Christina T; Ostermann Helmut; Kolb Hans-Jochem; Fiegl Michael; Huppmann Saskia; Morgenstern Nicole; Tischer Johanna
A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients.
Annals of hematology 2008;87(11):915-22.
2008: Gerbitz Armin; Hillemanns Patrick; Schmid Christoph; Wilke Andrea; Jayaraman Rajshri; Kolb Hans-Jochem; Eissner Gunther; Holler Ernst
Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(10):1180-9.
2008: Flowers Mary E D; Apperley Jane F; van Besien Koen; Elmaagacli Ahmet; Grigg Andrew; Reddy Vijay; Bacigalupo Andrea; Kolb Hans-Jochem; Bouzas Luis; Michallet Mauricette; Prince H Miles; Knobler Robert; Parenti Dennis; Gallo Jose; Greinix Hildegard T
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.
Blood 2008;112(7):2667-74.
2008: Schuster Friedhelm R; Buhmann Raymund; Reuther Susanne; Hubner Bernd; Grabrucker Christine; Liepert Anja; Reibke Roland; Lichtner Peter; Yang Ting; Kroell Tanja; Kolb Hans-Jochem; Borkhardt Arndt; Schmetzer Helga
Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.
Cancer genomics & proteomics 2008;5(5):275-86.
2008: Schneider Marlon R; Wolf Eckhard; Braun Joachim; Kolb Hans-Jochem; Adler Heiko
Canine embryo-derived stem cells and models for human diseases.
Human molecular genetics 2008;17(R1):R42-7.
2008: Schmid C; Schleuning M; Hentrich M; Markl G E; Gerbitz A; Tischer J; Ledderose G; Oruzio D; Hiddemann W; Kolb H-J
High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission.
Bone marrow transplantation 2008;41(8):721-7.
2008: Hauer Julia; Tosi Sabrina; Schuster Friedhelm R; Harbott Jochen; Kolb Hans-Jochem; Borkhardt Arndt
Graft versus leukemia effect after haploidentical HSCT in a MLL-negative infant AML with HLXB9/ETV6 rearrangement.
Pediatric blood & cancer 2008;50(4):921-3.
2008: Kyriakou Charalampia; Canals Carmen; Goldstone Anthony; Caballero Dolores; Metzner Bernd; Kobbe Guido; Kolb Hans-Jochem; Kienast Joachim; Reimer Peter; Finke Jurgen; Oberg Gunnar; Hunter Ann; Theorin Niklas; Sureda Anna; Schmitz Norbert;
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):218-24.
2008: Ostronoff L K; Kremmer E; Fermín M L; Fragío C; Mysliwietz J; Kolb H-J; Tejero C
Canine stem cell factor augments expression of matrix metalloproteinase-9 by CD34 cells.
Cytotherapy 2008;10(2):193-202.
2007: Schmid Christoph; Labopin Myriam; Nagler Arnon; Bornhäuser Martin; Finke Jürgen; Fassas Athanasios; Volin Liisa; Gürman Günham; Maertens Johan; Bordigoni Pierre; Holler Ernst; Ehninger Gerhard; Polge Emmanuelle; Gorin Norbert-Claude; Kolb Hans-Jochem; Rocha Vanderson;
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4938-45.
2007: Schuster Ingrid G; Busch Dirk H; Eppinger Elfriede; Kremmer Elisabeth; Milosevic Slavoljub; Hennard Christine; Kuttler Christina; Ellwart Joachim W; Frankenberger Bernhard; Nössner Elfriede; Salat Christoph; Bogner Christian; Borkhardt Arndt; Kolb Hans-Jochem; Krackhardt Angela M
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies.
Blood 2007;110(8):2931-9.
2007: Schneider Marlon R; Adler Heiko; Braun Joachim; Kienzle Beate; Wolf Eckhard; Kolb Hans-Jochem
Canine embryo-derived stem cells--toward clinically relevant animal models for evaluating efficacy and safety of cell therapies.
Stem cells (Dayton, Ohio) 2007;25(7):1850-1.
2007: Schmetzer H M; Kremser A; Loibl J; Kroell T; Kolb H-J
Quantification of ex vivo generated dendritic cells (DC) and leukemia-derived DC contributes to estimate the quality of DC, to detect optimal DC-generating methods or to optimize DC-mediated T-cell-activation-procedures ex vivo or in vivo.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(6):1338-41.
2007: Weissinger Eva M; Schiffer Eric; Hertenstein Bernd; Ferrara James L; Holler Ernst; Stadler Michael; Kolb Hans-Jochem; Zander Axel; Zürbig Petra; Kellmann Markus; Ganser Arnold
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Blood 2007;109(12):5511-9.
2007: Hehlmann Rüdiger; Berger Ute; Pfirrmann Markus; Heimpel Hermann; Hochhaus Andreas; Hasford Joerg; Kolb Hans-Jochem; Lahaye Tanja; Maywald Ole; Reiter Andreas; Hossfeld Dieter K; Huber Christoph; Löffler Helmut; Pralle Hans; Queisser Wolfgang; Tobler Andreas; Nerl Christoph; Solenthaler Max; Goebeler Mariele E; Griesshammer Martin; Fischer Thomas; Kremers Stephan; Eimermacher Hartmut; Pfreundschuh Michael; Hirschmann Wolf-Dietrich; Lechner Klaus; Wassmann Barbara; Falge Christiane; Kirchner Hartmut H; Gratwohl Alois
Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia.
Blood 2007;109(11):4686-92.
2007: Schmid Christoph; Kolb Hans-Jochem
[Allogeneic stem cell transplantation in the management of acute myeloid leukemia]
Medizinische Klinik (Munich, Germany : 1983) 2007;102(4):317-23.
2007: Weisser Martin; Schleuning Michael; Haferlach Claudia; Schwerdtfeger Rainer; Kolb Hans Jochem
Allogeneic stem-cell transplantation provides excellent results in advanced stage chronic myeloid leukemia with major cytogenetic response to pre-transplant imatinib therapy.
Leukemia & lymphoma 2007;48(2):295-301.
2006: Hentschel N; Krusch M; Kiener P A; Kolb H J; Salih H R; Schmetzer H M
Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
European journal of haematology 2006;77(2):91-101.
2006: Schmid Christoph; Schleuning Michael; Schwerdtfeger Rainer; Hertenstein Bernd; Mischak-Weissinger Eva; Bunjes Donald; Harsdorf Stephanie V; Scheid Christoph; Holtick Udo; Greinix Hildegard; Keil Felix; Schneider Barbara; Sandherr Michael; Bug Gesine; Tischer Johanna; Ledderose Georg; Hallek Michael; Hiddemann Wolfgang; Kolb Hans-Jochem
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.
Blood 2006;108(3):1092-9.
2006: Pihusch Verena; Rank Andreas; Steber Ruth; Pihusch Markus; Pihusch Rudolf; Toth Bettina; Hiller Erhard; Kolb Hans-Jochem
Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients.
Transplantation 2006;81(10):1405-9.
2006: Weisser Martin; Tischer Johanna; Schnittger Susanne; Schoch Claudia; Ledderose Georg; Kolb Hans Jochem
A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.
Haematologica 2006;91(5):663-6.
2006: Gratwohl Alois; Brand Ronald; Apperley Jane; Crawley Charles; Ruutu Tapani; Corradini Paolo; Carreras Enric; Devergie Agnes; Guglielmi Cesare; Kolb Hans-Jochen; Niederwieser Dietger;
Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Haematologica 2006;91(4):513-21.
2006: Maywald O; Pfirrmann M; Berger U; Breitscheidel L; Gratwohl A; Kolb H-J; Beelen D W; Tobler A; Metzgeroth G; Gnad S U; Hochhaus A; Hasford J; Hehlmann R; Reiter A;
Cytogenetic response to prior treatment with interferon-alpha is predictive for survival after allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(3):477-84.
2006: Pihusch Markus; Pihusch Rudolf; Fraunberger Peter; Pihusch Verena; Andreesen Reinhard; Kolb Hans-Jochem; Holler Ernst
Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.
European journal of haematology 2006;76(2):93-101.
2006: Rieger Christina; Rank Andreas; Fiegl Michael; Tischer Johanna; Schiel Xaver; Ostermann Helmut; Kolb Hans-Jochem
Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier Syndrome.
Thrombosis and haemostasis 2006;95(1):190-1.
2006: Boeck S; Hamann M; Pihusch V; Heller T; Diem H; Rolf B; Pihusch R; Kolb H-J; Pihusch M
Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
Bone marrow transplantation 2006;37(1):57-64.
2006: Duell Thomas; Poleck-Dehlin Brigitte; Schmid Christoph; Wunderlich Bettina; Ledderose Georg; Mittermuller Johann; Kolb Hans Jochen; Schmetzer Helga
Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia.
Acta haematologica 2006;116(2):131-6.
2005: Aoudjhane M; Labopin M; Gorin N C; Shimoni A; Ruutu T; Kolb H-J; Frassoni F; Boiron J M; Yin J L; Finke J; Shouten H; Blaise D; Falda M; Fauser A A; Esteve J; Polge E; Slavin S; Niederwieser D; Nagler A; Rocha V;
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(12):2304-12.
2005: Pihusch Markus; Wegner Holger; Goehring Peter; Salat Christoph; Pihusch Verena; Hiller Erhard; Andreesen Reinhard; Kolb Hans-Jochem; Holler Ernst; Pihusch Rudolf
Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients.
Transplantation 2005;80(10):1376-82.
2005: Stemmler H J; Menzel H; Salat C; Lindhofer H; Kahlert S; Heinemann V; Kolb H J
Lasting remission following multimodal treatment in a patient with metastatic breast cancer.
Anti-cancer drugs 2005;16(10):1135-7.
2005: Fiegl Michael; Gerbitz Armin; Gaeta Antonia; Campe Hartmut; Jaeger Gundula; Kolb Hans-Jochem
Recovery from CMV esophagitis after allogeneic bone marrow transplantation using non-myeloablative conditioning: the role of immunosuppression.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2005;34(3):219-23.
2005: Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Andreesen R; Kolb H-J; Holler E; Pihusch R
Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2005;36(7):631-7.
2005: Pihusch Markus; Boeck Stefan; Hamann Moritz; Pihusch Verena; Heller Tatjana; Diem Heinz; Rolf Burkhard; Pihusch Rudolf; Andreesen Reinhard; Holler Ernst; Kolb Hans-Jochem
Peripheral dendritic cell chimerism in allogeneic hematopoietic stem cell recipients.
Transplantation 2005;80(6):843-9.
2005: Schmid Christoph; Schleuning Michael; Ledderose Georg; Tischer Johanna; Kolb Hans-Jochem
Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5675-87.
2005: León Leticia G; Ostronoff Luciana K; Fermín María Luisa; Fragío Cristina; Kremmer Elisabeth; Kolb Hans-Jochem; Tejero Concepción
In vitro generation of mature neutrophils from canine Lin- bone marrow cells.
Veterinary immunology and immunopathology 2005;107(1-2):41-50.
2005: Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb H J; Schmetzer H M
Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Scandinavian journal of immunology 2005;62(1):86-98.
2005: Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb H J; Schmetzer H M
Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
Scandinavian journal of immunology 2005;62(1):75-85.
2005: Stemmler H J; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb H J
Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
Anticancer research 2005;25(4):3047-54.
2005: Wiesner Martina; Zentz Caroline; Hammer Markus H; Cobbold Mark; Kern Florian; Kolb Hans-Jochem; Hammerschmidt Wolfgang; Zeidler Reinhard; Moosmann Andreas
Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines.
European journal of immunology 2005;35(7):2110-21.
2005: Berger U; Maywald O; Pfirrmann M; Lahaye T; Hochhaus A; Reiter A; Hasford J; Heimpel H; Hossfeld D K; Kolb H-J; Löffler H; Pralle H; Queisser W; Hehlmann R;
Gender aspects in chronic myeloid leukemia: long-term results from randomized studies.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):984-9.
2005: Reiter Andreas; Walz Christoph; Watmore Ann; Schoch Claudia; Blau Ilona; Schlegelberger Brigitte; Berger Ute; Telford Nick; Aruliah Shilani; Yin John A; Vanstraelen Danny; Barker Helen F; Taylor Peter C; O'Driscoll Aisling; Benedetti Fabio; Rudolph Cornelia; Kolb Hans-Jochem; Hochhaus Andreas; Hehlmann Rüdiger; Chase Andrew; Cross Nicholas C P
The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.
Cancer research 2005;65(7):2662-7.
2005: Oh Hakumei; Loberiza Fausto R; Zhang Mei-jie; Ringdén Olle; Akiyama Hideki; Asai Takayoshi; Miyawaki Shuichi; Okamoto Shinichiro; Horowitz Mary M; Antin Joseph H; Bashey Asad; Bird Jennifer M; Carabasi Matthew H; Fay Joseph W; Gale Robert Peter; Giller Roger H; Goldman John M; Hale Gregory A; Harris Richard E; Henslee-Downey Jean; Kolb Hans-Jochem; Litzow Mark R; McCarthy Philip L; Neudorf Steven M; Serna Derek S; Socié Gerard; Tiberghien Pierre; Barrett A John
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
Blood 2005;105(4):1408-16.
2005: Hentrich Marcus; Oruzio Daniel; Jäger Gundula; Schlemmer Marcus; Schleuning Michael; Schiel Xaver; Hiddemann Wolfgang; Kolb Hans-Jochem
Impact of human herpesvirus-6 after haematopoietic stem cell transplantation.
British journal of haematology 2005;128(1):66-72.
2005: Kolb Hans-Jochem; Schmid Christoph; Buhmann Raymund; Tischer Johanna; Ledderose Georg
DLI: where are we know?
Hematology (Amsterdam, Netherlands) 2005;10 Suppl 1():115-6.
2005: Pihusch Verena; Pihusch Markus; Penovici Marius; Kolb Hans J; Hiller Erhard; Pihusch Rudolf
Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
Thrombosis research 2005;116(3):233-40.
2004: Weisser M; Schleuning M; Ledderose G; Rolf B; Schnittger S; Schoch C; Schwerdtfeger R; Kolb H J
Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.
Bone marrow transplantation 2004;34(12):1083-8.
2004: Kolb Hans-Jochem; Rank Andreas; Chen Xiao; Woiciechowsky Anja; Roskrow Marie; Schmid Christoph; Tischer Johanna; Ledderose Georg
In-vivo generation of leukaemia-derived dendritic cells.
Best practice & research. Clinical haematology 2004;17(3):439-51.
2004: Pihusch Markus; Lohse Peter; Reitberger Jill; Hiller Erhard; Andreesen Reinhard; Kolb Hans-Jochem; Holler Ernst; Pihusch Rudolf
Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(6):911-8.
2004: Scheinkönig C; Kappicht S; Kolb H-J; Schleuning M
Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells.
Bone marrow transplantation 2004;34(6):531-6.
2004: Voltz Raymond; Starck Michaela; Zingler Vera; Strupp Michael; Kolb Hans-Jochem
Mitoxantrone therapy in multiple sclerosis and acute leukaemia: a case report out of 644 treated patients.
Multiple sclerosis (Houndmills, Basingstoke, England) 2004;10(4):472-4.
2004: Schmid C; Schleuning M; Aschan J; Ringdén O; Hahn J; Holler E; Hegenbart U; Niederwieser D; Dugas M; Ledderose G; Kolb H-J
Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(8):1430-3.
2004: Weissinger E M; Oettrich K; Evans C; Genieser H-G; Schwede F; Dangers M; Dammann E; Kolb H-J; Mischak H; Ganser A; Kolch W
Activation of protein kinase A (PKA) by 8-Cl-cAMP as a novel approach for antileukaemic therapy.
British journal of cancer 2004;91(1):186-92.
2004: Kaiser Thorsten; Kamal Haytham; Rank Andreas; Kolb Hans-Jochem; Holler Ernst; Ganser Arnold; Hertenstein Bernd; Mischak Harald; Weissinger Eva Maria
Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(2):340-9.
2004: Hoeflich Andreas; Bünger Lutz; Nedbal Sabine; Renne Ulla; Elmlinger Martin W; Blum Werner F; Bruley Charlotte; Kolb Helmut J; Wolf Eckhard
Growth selection in mice reveals conserved and redundant expression patterns of the insulin-like growth factor system.
General and comparative endocrinology 2004;136(2):248-59.
2004: Kolb Hans-Jochem; Simoes Belinda; Schmid Christoph
Cellular immunotherapy after allogeneic stem cell transplantation in hematologic malignancies.
Current opinion in oncology 2004;16(2):167-73.
2004: Kolb Hans-Jochem; Schmid Christoph; Barrett A John; Schendel Dolores J
Graft-versus-leukemia reactions in allogeneic chimeras.
Blood 2004;103(3):767-76.
2004: Fermín M L; Gaitán S; Fragío C; Léon L G; Ostronoff L K; Kremmer E; Kolb H J; Tejero C
Canine long-term bone marrow culture neutrophil production and functionality.
Acta haematologica 2004;111(4):196-204.
2004: Schleuning Michael; Buxbaum-Conradi Harald; Jäger Gundula; Kolb Hans-Jochem
Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):135-44.
2003: Hoeflich A; Fettscher O; Preta G; Lahm H; Kolb H J; Wolf E; Weber M M
Increased activity of catalase in tumor cells overexpressing IGFBP-2.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2003;35(11-12):816-21.
2003: Wahl Ulrich; Nössner Elfriede; Kronenberger Konrad; Gangnus Rainer; Pohla Heike; Staege Martin S; Kolb Hans-Jochem; Hallek Michael; Mocikat Ralph
Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: preclinical evaluation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(11):4240-6.
2003: Berger U; Engelich G; Maywald O; Pfirrmann M; Hochhaus A; Reiter A; Metzgeroth G; Gnad U; Hasford J; Heinze B; Heimpel H; Hossfeld D K; Kolb H-J; Löffler H; Pralle H; Queisser W; Hehlmann R;
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(9):1820-6.
2003: Bittmann Iris; Hentrich Markus; Bise Karl; Kolb Hans Jochem; Löhrs Udo
Endothelial cells but not epithelial cells or cardiomyocytes are partially replaced by donor cells after allogeneic bone marrow and stem cell transplantation.
Journal of hematotherapy & stem cell research 2003;12(4):359-66.
2003: Zander A R; Kröger N; Schleuning M; Finke J; Zabelina T; Beelen D; Schwerdtfeger R; Baurmann H; Bornhäuser M; Ehninger G; Fauser A A; Kiehl M; Trenschel R; Ottinger H D; Bertz H; Berger J; Kolb H-J; Schaefer U W
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone marrow transplantation 2003;32(4):355-61.
2003: Schleuning M; Günther W; Tischer J; Ledderose G; Kolb H-J
Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.
Bone marrow transplantation 2003;32(3):243-50.
2003: Kern Wolfgang; Danhauser-Riedl Susanne; Ratei Richard; Schnittger Susanne; Schoch Claudia; Kolb Hans-Jochem; Ludwig Wolf-Dieter; Hiddemann Wolfgang; Haferlach Torsten
Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
Haematologica 2003;88(6):646-53.
2003: Weber Martin; Lange Claudia; Günther Wolfgang; Franz Monika; Kremmer Elisabeth; Kolb Hans-Jochem
Minor histocompatibility antigens on canine hemopoietic progenitor cells.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(12):5861-8.
2003: Kolb Hans-Jochem; Guenther Wolfgang; Gyurkocza Boglarka; Hoetzl Florian; Simoes Belinda; Falk Christine; Schleuning Michael; Ledderose Georg
Tolerance and chimerism.
Transplantation 2003;75(9 Suppl):26S-31S.
2003: Sostak P; Padovan C S; Yousry T A; Ledderose G; Kolb H-J; Straube A
Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.
Neurology 2003;60(5):842-8.
2003: Padovan C S; Sostak P; Reich P; Kolb H-J; Müller-Felber W; Straube A
[Neuromuscular complications after allogeneic bone marrow transplantation]
Der Nervenarzt 2003;74(2):159-66.
2003: Kolb Hans-Jochem; Schmid Christoph; Chen Xiao; Woiciechowski Anja; Roskrow Marie; Weber Martin; Guenther Wolfgang; Ledderose Georg; Schleuning Michael
Adoptive immunotherapy in chimeras with donor lymphocytes.
Acta haematologica 2003;110(2-3):110-20.
2002: Gratwohl Alois; Brand Ronald; Apperley Jane; Biezen Av Anja v; Bandini Giuseppe; Devergie Agnes; Schattenberg Anton; Frassoni Francesco; Guglielmi Cesare; Iacobelli Simona; Michallet Mauricette; Kolb Hans-Jochen; Ruutu Tapani; Niederwieser Dietger;
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.
Blood 2002;100(12):3877-86.
2002: Pihusch Rudolf; Salat Christoph; Schmidt Edwin; Göhring Peter; Pihusch Markus; Hiller Erhard; Holler Ernst; Kolb Hans-Jochem
Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.
Transplantation 2002;74(9):1303-9.
2002: Schmid C; Weisser M; Ledderose G; Stötzer O; Schleuning M; Kolb H-J
[Dose-reduced conditioning before allogeneic stem cell transplantation: principles, clinical protocols and preliminary results]
Deutsche medizinische Wochenschrift (1946) 2002;127(42):2186-92.
2002: Pihusch R; Wegner H; Salat C; Pihusch M; Holler E; Kolb H J; Hiller E
Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2002;30(6):381-7.
2002: Pihusch R; Holler E; Mühlbayer D; Göhring P; Stötzer O; Pihusch M; Hiller E; Kolb H-J
The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation.
Bone marrow transplantation 2002;30(6):347-54.
2002: Pihusch R; Höhnberg B; Salat C; Pihusch M; Hiller E; Kolb H J
Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation.
Annals of hematology 2002;81(8):454-61.
2002: Guglielmi Cesare; Arcese William; Dazzi Francesco; Brand Ronald; Bunjes Donald; Verdonck Leo F; Schattenberg Anton; Kolb Hans-Jochem; Ljungman Per; Devergie Agnes; Bacigalupo Andrea; Gomez Marta; Michallet Mauricette; Elmaagacli Ahmet; Gratwohl Alois; Apperley Jane; Niederwieser Dietger
Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose.
Blood 2002;100(2):397-405.
2002: Pihusch Rudolf; Salat Christoph; Göhring Peter; Hentrich Markus; Wegner Holger; Pihusch Markus; Hiller Erhard; Kolb Hans-Jochem; Ostermann Helmut
Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut.
British journal of haematology 2002;117(2):469-76.
2002: Fiegler Heike; Knabel Michael; Franz Monika; Kolb Hans Jochem; Just Ursula
Determination of donor-type chimerism using a semi-quantitative PCR-based method in a canine model for bone marrow transplantation.
Veterinary immunology and immunopathology 2002;84(1-2):61-70.
2002: Schleuning Michael; Stoetzer Oliver; Waterhouse Christine; Schlemmer Markus; Ledderose Georg; Kolb Hans-Jochem
Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease.
Experimental hematology 2002;30(1):7-10.
2002: Kolb H J; Schmid Ch; Weisser M; Pihusch M; Tischer J; Pihusch R; Stoetzer O; Ledderose G; Schleuning M
Cytoreduction, DLI, or mobilized peripheral blood progenitors.
Annals of hematology 2002;81 Suppl 2():S30-3.
2001: Hoeflich A; Reisinger R; Lahm H; Kiess W; Blum W F; Kolb H J; Weber M M; Wolf E
Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?
Cancer research 2001;61(24):8601-10.
2001: Kolb H J; Mischak-Weissinger E
[Cell therapy of hematological neoplasms]
Der Internist 2001;42(10):1374-83.
2001: Stötzer O J; Schleuning M; Ledderose G; Hiddemann W; Kolb H J
[Allogeneic transplantation in malignant lymphoma]
Deutsche medizinische Wochenschrift (1946) 2001;126(39):1062-9.
2001: Schulz U; Munker R; Ertl B; Holler E; Kolb H J
Different types of human leukemias express the message for TNF-alpha and interleukin-10.
European journal of medical research 2001;6(8):359-63.
2001: Hoeflich A; Nedbal S; Blum W F; Erhard M; Lahm H; Brem G; Kolb H J; Wanke R; Wolf E
Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2.
Endocrinology 2001;142(5):1889-98.
2001: Munker R; Salat C; Pihusch R; Diem H; Hiller E; Glass J; Kolb H J; Yu H
Levels of insulin-like growth factor after stem cell transplantation.
European journal of medical research 2001;6(4):181-4.
2001: Woiciechowsky A; Regn S; Kolb H J; Roskrow M
Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(2):246-55.
2001: Regn S; Raffegerst S; Chen X; Schendel D; Kolb H J; Roskrow M
Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant.
Bone marrow transplantation 2001;27(1):53-64.
2000: Chen X; Woiciechowsky A; Raffegerst S; Schendel D; Kolb H J; Roskrow M
Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis.
British journal of haematology 2000;111(3):817-25.
2000: Chen X; Regn S; Raffegerst S; Kolb H J; Roskrow M
Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia.
British journal of haematology 2000;111(2):596-607.
2000: Huss R; Weissinger E M; Lange C; Gatsios P; Eissner G; Kolb H J; Diebold J; Heinrich P C; Graeve L
In vitro-generated stem cell leukaemia showing altered cell cycle progression with distinct signalling of the tyrosine-phosphorylated rasGAP-associated p62(dok) protein.
The Journal of pathology 2000;192(3):363-72.
2000: Ottinger H D; Müller C; Schmitz N; Kubanek B; Arnold R; Ebell W; Eberhard H P; Ehninger G; Fronz U; Goldmann S; Grosse-Wilde H; Havers W; Klingebiel T; Kolb H J; Seeber S; Schaefer U W; Baldomero H; Gratwohl A
Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation.
Annals of hematology 2000;79(8):437-43.
2000: Huss R; Gatsios P; Graeve L; Lange C; Eissner G; Kolb H J; Thalmeier K; Heinrich P C
Quiescence of CD34-negative haematopoietic stem cells is mediated by downregulation of Cyclin B and no stat activation.
Cytokine 2000;12(8):1195-204.
2000: Guglielmi C; Arcese W; Hermans J; Bacigalupo A; Bandini G; Bunjes D; Carreras E; Devergie A; Frassoni F; Goldman J; Gratwohl A; Kolb H J; Iori A P; Niederwieser D; Prentice H G; de Witte T; Apperley J
Risk assessment in patients with Ph+ chronic myelogenous leukemia at first relapse after allogeneic stem cell transplant: an EBMT retrospective analysis. The Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2000;95(11):3328-34.
2000: Hoeflich A; Fettscher O; Lahm H; Blum W F; Kolb H J; Engelhardt D; Wolf E; Weber M M
Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells.
Cancer research 2000;60(4):834-8.
2000: Holler E; Roncarolo M G; Hintermeier-Knabe R; Eissner G; Ertl B; Schulz U; Knabe H; Kolb H J; Andreesen R; Wilmanns W
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation.
Bone marrow transplantation 2000;25(3):237-41.
2000: Huss R; Lange C; Weissinger E M; Kolb H J; Thalmeier K
Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics.
Stem cells (Dayton, Ohio) 2000;18(4):252-60.
1999: Hoeflich A; Wu M; Mohan S; Föll J; Wanke R; Froehlich T; Arnold G J; Lahm H; Kolb H J; Wolf E
Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain.
Endocrinology 1999;140(12):5488-96.
1999: Hehlmann R; Hochhaus A; Kolb H J; Hasford J; Gratwohl A; Heimpel H; Siegert W; Finke J; Ehninger G; Holler E; Berger U; Pfirrmann M; Muth A; Zander A; Fauser A A; Heyll A; Nerl C; Hossfeld D K; Löffler H; Pralle H; Queisser W; Tobler A
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure.
Blood 1999;94(11):3668-77.
1999: Kolb H J; Socié G; Duell T; Van Lint M T; Tichelli A; Apperley J F; Nekolla E; Ljungman P; Jacobsen N; van Weel M; Wick R; Weiss M; Prentice H G
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
Annals of internal medicine 1999;131(10):738-44.
1999: Lange C; Kaltz C; Thalmeier K; Kolb H J; Huss R
Hematopoietic reconstitution of syngeneic mice with a peripheral blood-derived, monoclonal CD34-, Sca-1+, Thy-1(low), c-kit+ stem cell line.
Journal of hematotherapy & stem cell research 1999;8(4):335-42.
1999: Padovan C S; Bise K; Hahn J; Sostak P; Holler E; Kolb H J; Straube A
Angiitis of the central nervous system after allogeneic bone marrow transplantation?
Stroke; a journal of cerebral circulation 1999;30(8):1651-6.
1999: Brandl M; Grosse-Hovest L; Holler E; Kolb H J; Jung G
Bispecific antibody fragments with CD20 X CD28 specificity allow effective autologous and allogeneic T-cell activation against malignant cells in peripheral blood and bone marrow cultures from patients with B-cell lineage leukemia and lymphoma.
Experimental hematology 1999;27(8):1264-70.
1999: Bosch T; Buhmann R; Lennertz A; Samtleben W; Kolb H J
Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation.
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 1999;3(3):252-6.
1999: Socié G; Stone J V; Wingard J R; Weisdorf D; Henslee-Downey P J; Bredeson C; Cahn J Y; Passweg J R; Rowlings P A; Schouten H C; Kolb H J; Klein J P
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
The New England journal of medicine 1999;341(1):14-21.
1999: Salat C; Holler E; Hiller E; Pihusch R; Kolb H J
Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.
Haematologica 1999;84 Suppl EHA-4():40-3.
1999: Cohen A; Rovelli A; Bakker B; Uderzo C; van Lint M T; Esperou H; Gaiero A; Leiper A D; Dopfer R; Cahn J Y; Merlo F; Kolb H J; Socié G
Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT.
Blood 1999;93(12):4109-15.
1999: Cohen A; Duell T; Socié G; van Lint M T; Weiss M; Tichelli A; Rovelli A; Apperley J F; Ljungman P; Kolb H J
Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1999;23(10):1043-7.
1999: Schleuning M; Jäger G; Holler E; Hill W; Thomssen C; Denzlinger C; Lorenz T; Ledderose G; Wilmanns W; Kolb H J
Human parvovirus B19-associated disease in bone marrow transplantation.
Infection 1999;27(2):114-7.
1999: Wendtner C M; Buhmann R; Kolb H J; Emmerich B; Hallek M
[Recurring vertigo and syncope in a patient with eosinophilia]
Der Internist 1999;40(3):305-10.
1999: Salat C; Holler E; Kolb H J; Pihusch R; Reinhardt B; Penovici M; Ledderose G; Hiller E
The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation.
Leukemia & lymphoma 1999;33(1-2):25-32.
1999: Schleuning M; Mittermüller J; Kolb H J
Bcr-abl protein detection in peripheral blood mononuclear cells for follow-up of chronic myelogenous leukaemia patients.
European journal of haematology 1999;62(3):149-54.
1998: Neumeister P; Hiller E; Gawaz M; Holler E; Kolb H J; Sill H; Pihusch R; Mempel W; Wittmann G; Salat C
Changes in platelet membrane glycoproteins before bone marrow transplantation and after engraftment--a pilot study.
European journal of medical research 1998;3(10):465-9.
1998: Ismair M G; Ries C; Lottspeich F; Zang C; Kolb H J; Petrides P E
Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1998;12(7):1136-43.
1998: Padovan C S; Yousry T A; Schleuning M; Holler E; Kolb H J; Straube A
Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation.
Annals of neurology 1998;43(5):627-33.
1998: Hoeflich A; Schmidt P; Föll J; Rottmann O; Weber M M; Kolb H J; Pirchner F; Wolf E
Altered growth of mice divergently selected for body weight is associated with complex changes in the growth hormone/insulin-like growth factor system.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1998;8(2):113-23.
1998: Gale R P; Hehlmann R; Zhang M J; Hasford J; Goldman J M; Heimpel H; Hochhaus A; Klein J P; Kolb H J; McGlave P B; Passweg J R; Rowlings P A; Sobocinski K A; Horowitz M M
Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group.
Blood 1998;91(5):1810-9.
1998: Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel M P; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb H J; Aul C; Apperley J
Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1998;21(3):255-61.
1997: Kolb H J; Poetscher C
Late effects after allogeneic bone marrow transplantation.
Current opinion in hematology 1997;4(6):401-7.
1997: Link H; Kolb H J; Ebell W; Hossfeld D K; Zander A; Niethammer D; Wandt H; Grosse-Wilde H; Schaefer U W
[Transplantation of hematopoietic stem cells. II: Indications for transplantation of hematopoietic stem cells after myeloablative therapy]
Medizinische Klinik (Munich, Germany : 1983) 1997;92(9):534-45.
1997: Link H; Kolb H J; Ebell W; Hossfeld D K; Zander A; Niethammer D; Wandt H; Grosse-Wilde H; Schaefer U W
[Transplantation of hematopoietic stem cells. I: Definitions, principle indications, complications]
Medizinische Klinik (Munich, Germany : 1983) 1997;92(8):480-91, 505.
1997: Ottinger H D; Albert E; Arnold R; Beelen D W; Blasczyk R; Bunjes D; Burdach S; Ebell W; Ehninger G; Einsele H; Enczmann J; Fauser A; Friedrich W; Finke J; Göbel U; Goldmann S F; Gramatzki M; Helbig W; Kanz L; Klingebiel T; Kolb H J; Kühnl P; Löliger C; Müller C R; Grosse-Wilde H
German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1997;20(2):101-5.
1997: Devergie A; Apperley J F; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice H G; Jouet J P; Kolb H J; Herstenstein B; Bacigalupo A; Evensen S A; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark R E; Goldman J M; Gratwohl A
European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1997;20(1):11-9.
1997: Heinemann V; Bosse D; Jehn U; Kähny B; Wachholz K; Debus A; Scholz P; Kolb H J; Wilmanns W
Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.
Antimicrobial agents and chemotherapy 1997;41(6):1275-80.
1997: Ringdén O; Labopin M; Gluckman E; Hows J M; Bradley B A; Kolb H J; Fouillard L; Jacobsen N; Vernant J P; Witz F; Harousseau J L; Gorin N C
Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the International Marrow Unrelated Search and Transplant (IMUST) Study.
Bone marrow transplantation 1997;19(10):963-8.
1997: Szydlo R; Goldman J M; Klein J P; Gale R P; Ash R C; Bach F H; Bradley B A; Casper J T; Flomenberg N; Gajewski J L; Gluckman E; Henslee-Downey P J; Hows J M; Jacobsen N; Kolb H J; Lowenberg B; Masaoka T; Rowlings P A; Sondel P M; van Bekkum D W; van Rood J J; Vowels M R; Zhang M J; Horowitz M M
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1767-77.
1997: Salat C; Holler E; Kolb H J; Pihusch R; Reinhardt B; Hiller E
Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
Bone marrow transplantation 1997;19(9):909-14.
1997: Hehlmann R; Willer A; Heimpel H; Hasford J; Kolb H J; Pralle H; Hossfeld D K; Queisser W; Löffler H; Hochhaus A; Tobler A; Lengfelder E; Berger U; Leib-Mösch C
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 3():506-11.
1997: Holler E; Ertl B; Hintermeier-Knabe R; Roncarolo M G; Eissner G; Mayer F; Fraunberger P; Behrends U; Pfannes W; Kolb H J; Wilmanns W
Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation?
Leukemia & lymphoma 1997;25(3-4):217-24.
1997: Hehlmann R; Ansari H; Hasford J; Heimpel H; Hossfeld D K; Kolb H J; Löffler H; Pralle H; Queisser W; Reiter A; Hochhaus A
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study Group.
British journal of haematology 1997;97(1):76-85.
1997: Duell T; Mittermüller J; Schmetzer H M; Kolb H J; Wilmanns W
Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32).
Cancer genetics and cytogenetics 1997;94(2):91-4.
1997: Heinemann V; Kähny B; Jehn U; Mühlbayer D; Debus A; Wachholz K; Bosse D; Kolb H J; Wilmanns W
Serum pharmacology of amphotericin B applied in lipid emulsions.
Antimicrobial agents and chemotherapy 1997;41(4):728-32.
1997: Kolb H J; Holler E
Adoptive immunotherapy with donor lymphocyte transfusions.
Current opinion in oncology 1997;9(2):139-45.
1997: Salat C; Holler E; Kolb H J; Reinhardt B; Pihusch R; Wilmanns W; Hiller E
Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation.
Blood 1997;89(6):2184-8.
1997: Salat C; Holler E; Wolf C; Kolb H J; Reinhardt B; Pihusch R; Krämling H J; Heinemann V; Haller M; Hiller E
Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Bone marrow transplantation 1997;19(5):487-90.
1997: Nüssler V; Gieseler F; Zwierzina H; Gullis E; Pelka-Fleischer R; Diem H; Abenhardt W; Schmitt R; Langenmayer I; Wohlrab A; Kolb H J; Wilmanns W
Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression.
Annals of hematology 1997;74(2):57-64.
1997: Duell T; van Lint M T; Ljungman P; Tichelli A; Socié G; Apperley J F; Weiss M; Cohen A; Nekolla E; Kolb H J
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.
Annals of internal medicine 1997;126(3):184-92.
1997: Hinterberger W; Rowlings P A; Hinterberger-Fischer M; Gibson J; Jacobsen N; Klein J P; Kolb H J; Stevens D A; Horowitz M M; Gale R P
Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia.
Annals of internal medicine 1997;126(2):116-22.
1997: Kolb H J; Holler E
Hematopoietic transplantation: state of the art.
Stem cells (Dayton, Ohio) 1997;15 Suppl 1():151-7; discussion 158.
1996: Salat C; Holler E; Göhring P; Poley S; Kolb H J; Pihusch R; Reinhardt B; Krämling H J; Haller M; Hiller E
Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
European journal of medical research 1996;1(12):571-4.
1996: Hoeflich A; Yang Y; Huber S; Rascher W; Koepf G; Blum W F; Heinz-Erian P; Kolb H J; Kiess W
Expression of IGFBP-2, -3, and -4 mRNA during differentiation of Caco-2 colon epithelial cells.
The American journal of physiology 1996;271(5 Pt 1):E922-31.
1996: Hoeflich A; Yang Y; Rascher W; Blum W F; Huber S; Koepf G; Kolb H J; Kiess W
Coordinate expression of insulin-like growth factor II (IGF-II) and IGF-II/mannose-6-phosphate receptor mRNA and stable expression of IGF-I receptor mRNA during differentiation of human colon carcinoma cells (Caco-2).
European journal of endocrinology / European Federation of Endocrine Societies 1996;135(1):49-59.
1996: Tichelli A; Duell T; Weiss M; Socié G; Ljungman P; Cohen A; van Lint M; Gratwohl A; Kolb H J
Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.
Bone marrow transplantation 1996;17(6):1105-11.
1996: Hehlmann R; Heimpel H; Hossfeld D K; Hasford J; Kolb H J; Löffler H; Pralle H; Queisser W; Hochhaus A; Tichelli A; Fett W; Schmitz N; Reiter A; Griesshammer M; Pfeifer W; Bümler M; Kamp T; Tobler A; Eimermacher H; Kuse R; Berger U; Ansari H
Randomized study of the combination of hydroxyurea and interferon alpha versus hydroxyurea monotherapy during the chronic phase of chronic myelogenous leukemia (CML Study II). The German CML Study Group.
Bone marrow transplantation 1996;17 Suppl 3():S21-4.
1996: Kolb H J; Mittermüller J; Holler E; Thalmeier K; Bartram C R
Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia.
Bone marrow transplantation 1996;17(3):449-52.
1996: Botzler C; Kolb H J; Issels R D; Multhoff G
Noncytotoxic alkyl-lysophospholipid treatment increases sensitivity of leukemic K562 cells to lysis by natural killer (NK) cells.
International journal of cancer. Journal international du cancer 1996;65(5):633-8.
1995: Stachel D; Schmid I; Straka C; Handgretinger R; Kolb H J; Haas R J
Allogenic peripheral blood stem cell (PBSC) transplantation in two patients with graft failure.
Bone marrow transplantation 1995;16(6):839-42.
1995: Kolb H J; Schattenberg A; Goldman J M; Hertenstein B; Jacobsen N; Arcese W; Ljungman P; Ferrant A; Verdonck L; Niederwieser D; van Rhee F; Mittermueller J; de Witte T; Holler E; Ansari H;
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.
Blood 1995;86(5):2041-50.
1995: Holler E; Kolb H J; Mittermüller J; Kaul M; Ledderose G; Duell T; Seeber B; Schleuning M; Hintermeier-Knabe R; Ertl B
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F).
Blood 1995;86(3):890-9.
1994: Hehlmann R; Heimpel H; Hasford J; Kolb H J; Pralle H; Hossfeld D K; Queisser W; Löffler H; Hochhaus A; Heinze B
Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.
Blood 1994;84(12):4064-77.
1994: Salat C; Holler E; Reinhardt B; Kolb H J; Seeber B; Ledderose G; Mittermueller J; Duell T; Wilmanns W; Hiller E
Parameters of the fibrinolytic system in patients undergoing BMT: elevation of PAI-1 in veno-occlusive disease.
Bone marrow transplantation 1994;14(5):747-50.
1994: Schleuning M; Thomssen C; Kolb H J; Sauer H J; Wilmanns W
Treatment of refractory severe aplastic anemia with granulocyte colony stimulating factor and interleukin 3.
American journal of hematology 1994;46(3):250-1.
1994: Salat C; Holler E; Reinhardt B; Kolb H J; Pihusch R; Neumeister P; Hiller E
[Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation]
Medizinische Klinik (Munich, Germany : 1983) 1994;89(5):245-7.
1994: Hehlmann R; Kister P; Willer A; Simon M; Schenk M; Seifarth W; Papakonstantinou G; Saussele S; Kolb H J; Ansari H
Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8 Suppl 1():S127-32.
1994: Guenther W; Schumm M; Buettner M; Voss C; Kremmer E; Thierfelder S; Wilmanns W; Kolb H J
NK activity of canine blood and marrow cells.
Tissue antigens 1994;43(3):198-201.
1994: Voss C; Kremmer E; Schumm M; Günther W; Hoffmann-Fezer G; Kolb H J; Thierfelder S
Rat monoclonal antibodies against three different epitopes of the canine Thy-1 and their depletion capacity in vivo.
Tissue antigens 1994;43(3):193-7.
1994: Schumm M; Günther W; Kolb H J; Rieber P; Büttner M; Voss C; Kremmer E; Reitmeier P; Thierfelder S; Wilmanns W
Prevention of graft-versus-host disease in DLA-haplotype mismatched dogs and hemopoietic engraftment of CD6-depleted marrow with and without cG-CSF treatment after transplantation.
Tissue antigens 1994;43(3):170-8.
1993: Schleuning M; Thomssen C; Kolb H J; Sauer H; Wilmanns W
[61-year-old patient with hemorrhagic diathesis and fatigue]
Der Internist 1993;34(12):1141-5.
1993: Voss C; Kremmer E; Hoffmann-Fezer G; Schumm M; Günther W; Kolb H J; Thierfelder S
Identification and characterization of a mouse monoclonal antibody (M10) directed against canine (dog) CD8+ lymphocytes.
Veterinary immunology and immunopathology 1993;38(3-4):311-25.
1993: Hehlmann R; Heimpel H; Hasford J; Kolb H J; Pralle H; Hossfeld D K; Queisser W; Löffler H; Heinze B; Georgii A
Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.
Blood 1993;82(2):398-407.
1993: Kolb H J; Mittermüller J; Hertenstein H; Schumm M; Holler E; de Witte T; Günther W; Ljungman P; Goldman J M
Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party.
Seminars in hematology 1993;30(3 Suppl 3):37-9.
1993: Büttner M; Schumm M; Boenisch B; Rieber E P; Kolb H J
Spontaneous tumor cell cytotoxicity mediated by peripheral blood mononuclear leukocytes of the dog.
Natural immunity 1993;12(2):92-103.
1993: Holler E; Kolb H J; Hintermeier-Knabe R; Mittermüller J; Thierfelder S; Kaul M; Wilmanns W
Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
Transplantation proceedings 1993;25(1 Pt 2):1234-6.
1993: Hehlmann R; Heimpel H; Kolb H J; Heinze B; Hochhaus A; Griesshammer M; Pralle H; Queisser W P; Essers U; Falge C
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1.
Leukemia & lymphoma 1993;11 Suppl 1():159-68.
1993: Holler E; Kolb H J; Wilmanns W
Treatment of GVHD--TNF-antibodies and related antagonists.
Bone marrow transplantation 1993;12 Suppl 3():S29-31.
1993: Kolb H J; Mittermüller J; Günther W; Bartram C; Thalmaier K; Schumm M; Holler E; Lederose G
Adoptive immunotherapy in human and canine chimeras.
Bone marrow transplantation 1993;12 Suppl 3():S61-4.
1992: Hötzl C; Clemm C; Kolb H J; Bartl R; Mittermüller J; Keil F; Wilmanns W
[53-year-old patient with plethora, colic and dark urine]
Der Internist 1992;33(7):509-12.
1992: Seeber C; Hiller E; Holler E; Kolb H J
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT).
Thrombosis research 1992;66(4):373-83.
1992: Hehlmann R; Heimpel H; Griesshammer M; Kolb H J; Heinze B; Hossfeld D K; Wickramanayake P D; Essers U; Thiele J; Georgii A
Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 3():110S-114S.
1992: Kolb H J; Guenther W; Duell T; Socie G; Schaeffer E; Holler E; Schumm M; Horowitz M M; Gale R P; Fliedner T M
Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects.
Bone marrow transplantation 1992;10 Suppl 1():135-8.
1992: Schumm M; Kolb H J; Hahn J; Beisser K; Rieber P; Günther W; Büttner M; Wilmanns W; Thierfelder S
Graft versus host tolerance in dogs across one DLA-haplotype by depletion of CD6 positive cells.
Progress in clinical and biological research 1992;377():419-25.
1992: Heim M U; Böck M; Kolb H J; Schleuning M; Mempel W
Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases.
Vox sanguinis 1992;62(3):165-8.
1991: Hahn J; Kolb H J; Schumm M; Beisser K; Ellwart J; Rieber P; Maldacker J; Schwella N; Lösslein L K; Holler E
Immunological characterization of canine hematopoietic progenitor cells.
Annals of hematology 1991;63(4):223-6.
1991: Gleixner B; Kolb H J; Holler E; Liesenfeld S; Riedner C; Hiller E; Seeber C; Kempeni J; Möller A; Knabe H
Treatment of aGVHD with OKT3: clinical outcome and side-effects associated with release of TNF alpha.
Bone marrow transplantation 1991;8(2):93-8.
1991: Hötzl C; Kolb H J; Holler E; Hahn J; Schumm M; Beisser K; Mysliwietz J; Rieber P; Mempel W; Wilmanns W
Functional characterization of canine lymphocyte subsets.
Annals of hematology 1991;63(1):49-53.
1991: Ash R C; Horowitz M M; Gale R P; van Bekkum D W; Casper J T; Gordon-Smith E C; Henslee P J; Kolb H J; Lowenberg B; Masaoka T
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion.
Bone marrow transplantation 1991;7(6):443-52.
1991: Hill W; Greither L; Bartl R; Jehn U; Kolb H J; Wilmanns W
[Patient with decreased energy, dyspnea on exertion and splenomegaly]
Der Internist 1991;32(3):154-7.
1991: Hehlmann R; Heimpel H; Heinze B; Georgii A; Kolb H J; Hossfeld D K; von Wussow P; Hochhaus A; Griesshammer M; Diehl V
[Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]
Onkologie 1991;14(1):66-73.
1991: Holler E; Kolb H J; Gleixner B; Riedner C; Bartl R; Ledderose G; Sönnichsen A; Wilmanns W
[18-year-old patient with increasing exertional dyspnea and hemorrhagic diathesis]
Der Internist 1991;32(2):100-3.
1990: Kolb H J; Mittermüller J; Clemm C; Holler E; Ledderose G; Brehm G; Heim M; Wilmanns W
Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients.
Blood 1990;76(12):2462-5.
1990: Kolb H J; Bender-Götze C
Late complications after allogeneic bone marrow transplantation for leukaemia.
Bone marrow transplantation 1990;6(2):61-72.
1990: Clemm C; Wick M; Bartl R; Goebel M; Kolb H J
[Patient with anemia, thrombopenia and slight leukocytosis]
Der Internist 1990;31(6):423-6.
1990: Atkinson K; Horowitz M M; Gale R P; van Bekkum D W; Gluckman E; Good R A; Jacobsen N; Kolb H J; Rimm A A; Ringdén O
Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation.
Blood 1990;75(12):2459-64.
1990: Holler E; Kolb H J; Möller A; Kempeni J; Liesenfeld S; Pechumer H; Lehmacher W; Ruckdeschel G; Gleixner B; Riedner C
Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.
Blood 1990;75(4):1011-6.
1990: Horowitz M M; Gale R P; Sondel P M; Goldman J M; Kersey J; Kolb H J; Rimm A A; Ringdén O; Rozman C; Speck B
Graft-versus-leukemia reactions after bone marrow transplantation.
Blood 1990;75(3):555-62.
1990: Kolb H J; Lösslein L K; Beisser K; Schäffer E; Holler E; Schwella N; Hochhäusser E; Lehmacher W; Balk O; Thierfelder S
Dose rate and fractionation of total body irradiation in dogs: short and long term effects.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1990;18 Suppl 1():51-9.
1989: Jung G; Holler E; Kolb H J; Wilmanns W
[Therapy of a patient with graft versus host reaction following allogenic bone marrow transplantation with the monoclonal antibody OKT3 (Orthoclone OKT3)]
Der Internist 1989;30(6):386-8.
1989: Holler E; Kolb H J; Hiller E; Mraz W; Lehmacher W; Gleixner B; Seeber C; Jehn U; Gerhartz H H; Brehm G
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation.
Blood 1989;73(7):2018-24.
1989: Kolb H J; Holler E; Bender-Götze C; Walther U; Mittermüller J; Clemm C; Bauchinger M; Gerhartz H H; Brehm G; Ledderose G
Myeloablative conditioning for marrow transplantation in myelodysplastic syndromes and paroxysmal nocturnal haemoglobinuria.
Bone marrow transplantation 1989;4(1):29-34.
1989: Kolb H J; Bender-Götze C; Holler E; Mittermüller J; Grosse-Wilde H; Wank R; Eckstein R; Scholz S; Haas R J; Mempel W
Improved survival following HLA-incompatible bone marrow transplantation. Munich Cooperative Group of Bone Marrow Transplantation.
Folia haematologica (Leipzig, Germany : 1928) 1989;116(3-4):421-5.
1989: Kolb H J; Bender-Götze C; Haas R J; Holler E; Thierfelder S; Wilmanns W
Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group.
Folia haematologica (Leipzig, Germany : 1928) 1989;116(3-4):397-402.
1988: Gerhartz H H; Mittermüller J; Raghavachar A; Schmetzer H; Clemm C; Kolb H J; Bartram C C; Wolf H
Epstein-Barr virus-positive recipient type B-cells survive in a "complete chimera" after allogeneic bone-marrow transplantation.
International journal of cancer. Journal international du cancer 1988;42(5):672-6.
1988: Heim M U; Schleuning M; Eckstein R; Huhn D; Siegert W; Clemm C; Ledderose G; Kolb H J; Wilmanns W; Mempel W
Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation.
Transfusion 1988;28(3):272-5.
1988: Mysliwietz J J; Hoffmann-Fezer G; Thierfelder S; Kolb H J; Maldacker J
Recognition of two epitopes of an antigen present on canine T cells but not on hemopoietic progenitors by four monoclonal antibodies.
Transplantation 1988;45(2):443-8.
1987: Lösslein L K; Kolb H J; Porzsolt S; Schäffer E; Scholz S; Meissner H; Holler E; Wilmanns W; Thierfelder S
Hyperfractionation of total-body irradiation and engraftment of marrow from DLA-haploidentical littermates.
Transplantation proceedings 1987;19(1 Pt 3):2707-8.
1986: Gerhartz H H; Kolb H J; Clemm C; Wilmanns W
Clonogenic assays and engraftment in allogeneic bone marrow transplantation.
Bone marrow transplantation 1986;1(2):221-6.
1986: Mittermüller J; Kolb H J; Gerhartz H H; Wilmanns W
In vivo differentiation of leukaemic blasts and effect of low dose Ara-C in a marrow grafted patient with leukaemic relapse.
British journal of haematology 1986;62(4):757-62.
1985: Mittermüller J; Kolb H J; Gerhartz H H; Wilmanns W
Cytotoxic action of low dose Ara-C. Investigations in a marrow grafted patient with relapse.
Onkologie 1985;8(3):168-71.
1984: Holler E; Kolb H J; Bodenberger U; Eckstein R; Hoffmann-Fezer G; Linke R P; Mempel W; Rodt H; Thierfelder S
Serological identification and separation of canine lymphocyte subpopulations.
Experimental hematology 1984;12(10):774-81.
1983: Jehn U; Sauer H; Kolb H J; Fink M; Ledderose G; Brehm G; Wilmanns W; Eckstein R; Heim M; Mempel W; von Lieven H; Bunde E; Rohloff R; Balk O; Hochhäuser E
[Bone marrow transplantation in adults in acute leukemia, aplastic anemia and paroxysmal nocturnal hemoglobinuria. Results of the Medical Clinic IIi of LMU (Ludwig-Maximilians University) Munich]
Klinische Wochenschrift 1983;61(7):321-8.
1983: Rodt H; Thierfelder S; Bender-Götze C; Dopfer R; Haas F J; Janka G; Kolb H J; Link H; Netzel B; Niethammer D; Schüch K; Wilms K
Serological inhibition of graft versus host disease: recent results in 28 patients with leukemia.
Haematology and blood transfusion 1983;28():92-6.
1981: Rodt H; Netzel B; Kolb H J; Haas R J; Wilms K; Bender-Götze C; Wernet P; Janka G; Link H; Wilmanns W; Thierfelder S
[Bone marrow transplantation in acute leukemias: antibody treatment for suppression of graft-versus-host disease (author's transl)]
Blut 1981;43(2):113-8.
1981: Kolb H J; Wündisch G F; Spitzer I; Ochsler H; Stengel-Rutkowski L; Bender-Götze C; Albert E D; Sauer H; Ledderose G; Brehm G; Jehn U; Eckstein R; Mempel W; Wilmanns W; Haas R J; Helmig M; Netzel B; Belohradsky B; Janka G; Rodt H; Grosse-Wilde H; Thiel E; von Lieven H; Roloff R; Krimmel B L; Bunde E; Wank R; Schendel D
[Bone marrow transplantation for aplastic anaemia (author's transl)]
Klinische Wochenschrift 1981;59(7):325-42.
1981: Rodt H; Kolb H J; Netzel B; Haas R J; Wilms K; Götze C B; Link H; Thierfelder S
Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT.
Transplantation proceedings 1981;13(1 Pt 1):257-61.
1981: Netzel B; Haas R J; Rodt H; Kolb H J; Belohradsky B; Thierfelder S
Antileukemic, autologous bone marrow transplantation in childhood acute lymphoblastic leukemia.
Transplantation proceedings 1981;13(1 Pt 1):254-6.
1981: Kolb H J; Bender-Götze C; Albert E D; Haas R; Janka G
[Bone marrow transplantation for relapsed, acute leukaemia (author's transl)]
Klinische Wochenschrift 1981;59(6):251-66.
1981: Rodt H; Thierfelder S; Kolb H J; Netzel B; Haas R J; Wilms K; Bender-Götze C
The concept of GvHD-suppression by in vitro treatment with antisera.
Haematology and blood transfusion 1981;26():124-35.
1980: Sauer H; Jehn U; Kolb H J; Ledderose G; Wilmanns W
[Allogeneic bone marrow transplantation in a patient with bone marrow aplasia]
Der Internist 1980;21(7):400-5.
1980: Haas R J; Janka G; Netzel B; Rodt H; Thierfelder S; Helmig M; Eife R; Belohradsky B H; Kolb H J; Betke K
Antibody incubation of human marrow graft for prevention graft versus host disease.
Blut 1980;40(6):387-97.
1980: Netzel B; Haas R J; Rodt H; Kolb H J; Thierfelder S
Immunological conditioning of bone marrow for autotransplantation in childhood acute lymphoblastic leukaemia.
Lancet 1980;1(8182):1330-2.
1980: Kolb H J; Bodenberger U; Rodt H V; Rieder I; Netzel B; Grosse-Wilde H; Scholz S; Thierfelder S
Bone marrow transplantation in DLA-haploidentical canine littermates: fractionated total body irradiation (FTBI) and in vitro treatment of the marrow graft with anti-T-cell globulin (ATCG).
Haematology and blood transfusion 1980;25():61-71.

Sign-in to see more